← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Uk Health Security Agency
Salisbury
$24,274,475
Total funding
8
Grants
Funding over time
peak $7.7M · FY2009–25$10M$7.5M$5M$2.5M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$23,626,060 · 7
DOD$648,415 · 1
By mechanism
N01$23,626,060 · 7
—$648,415 · 1
Investigators at Uk Health Security Agency
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Technologies to Advance Next Generation Anthrax Vaccines$6,501,809
N01 · FY2012 · AI
Task 12 (D19) Testing of Antibiotics Against Inhalational Melioidosis and Glander$4,757,562
N01 · FY2009 · AI
Task C19: Efficacy of amoxicillin in NHP model of anthrax$2,156,042
N01 · FY2013 · AI
Task C15:The Development of Virus Banks, Reagents and Assays for Filoviruses$1,867,964
N01 · FY2013 · AI
Task C03: Evaluation of the Aerosol Monkeypox Model for Testing Antivirals$1,155,402
N01 · FY2012 · AI
Technologies to Advance Next Generation Anthrax Vaccines$1,010,295
N01 · FY2015 · AI
Task 01 (A01): In Vitro Screens for Antimicrobial Activity$939,865
N01 · FY2009 · AI
Task 02 (B01): Clinical Isolate Panels for Selected Bacterial Pathogens$753,491
N01 · FY2009 · AI
ECOLOGICAL AND EPIDEMIOLOGICAL INVESTIGATION OF CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS (CCHFV) IN AZERBAIJAN$648,415
· FY2025 · Defense Threat Reduction Agency
Task B14: Production of Well Characterized Challenge Material (WCCM) for BSL-3/BSL-4 Viral Pathogens.$613,999
N01 · FY2022 · AI
Task B14: Production of Well Characterized Challenge Material (WCCM) for Viral Pathogens$608,743
N01 · FY2023 · AI
Task 01/C1: In Vitro and Animal Models for Emerging IDs and Biodefense$466,435
N01 · FY2011 · AI
Task 3 (D04/D07): Characterization of Monkeypox animal models$454,700
N01 · FY2009 · AI
Task A55:Comparison of Natural Routes of Infection with Burkholderia pseudomallei$452,683
N01 · FY2013 · AI
Task B14: Production of Well Characterized Challenge Material (WCCM) for Viral Pathogens$439,260
N01 · FY2023 · AI
Task A69 A Clostridium difficile Hamster Model for In Vivo Assessment of Interventional Agents$394,213
N01 · FY2015 · AI
Task C03:EVALUATION OF THE AEROSOL MONKEYPOX MODEL FOR TESTING ANTIVIRALS$378,355
N01 · FY2013 · AI
Task A70: ADENOVIRUS MOUSE MODEL FOR EVALUATION OF MEDICAL COUNTERMEASURES AGAINST MERS$201,321
N01 · FY2014 · AI
Task A70: ADENOVIRUS MOUSE MODEL FOR EVALUATION OF MEDICAL COUNTERMEASURES AGAINST MERS$173,940
N01 · FY2016 · AI
Animal Models for Infectious Diseases Support$100,000
N01 · FY2017 · AI